chr5-128084006-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001046.3(SLC12A2):c.52G>T(p.Val18Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000742 in 1,254,116 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001046.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC12A2 | NM_001046.3 | c.52G>T | p.Val18Phe | missense_variant | 1/27 | ENST00000262461.7 | NP_001037.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC12A2 | ENST00000262461.7 | c.52G>T | p.Val18Phe | missense_variant | 1/27 | 1 | NM_001046.3 | ENSP00000262461 | P4 | |
SLC12A2 | ENST00000343225.4 | c.52G>T | p.Val18Phe | missense_variant | 1/26 | 1 | ENSP00000340878 | A2 | ||
SLC12A2 | ENST00000509205.5 | c.52G>T | p.Val18Phe | missense_variant, NMD_transcript_variant | 1/27 | 1 | ENSP00000427109 | |||
SLC12A2 | ENST00000628403.2 | c.52G>T | p.Val18Phe | missense_variant | 1/26 | 5 | ENSP00000486323 |
Frequencies
GnomAD3 genomes AF: 0.0000593 AC: 9AN: 151700Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.0000762 AC: 84AN: 1102416Hom.: 0 Cov.: 30 AF XY: 0.0000759 AC XY: 40AN XY: 527194
GnomAD4 genome AF: 0.0000593 AC: 9AN: 151700Hom.: 0 Cov.: 32 AF XY: 0.0000405 AC XY: 3AN XY: 74090
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 12, 2023 | The c.52G>T (p.V18F) alteration is located in exon 1 (coding exon 1) of the SLC12A2 gene. This alteration results from a G to T substitution at nucleotide position 52, causing the valine (V) at amino acid position 18 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 26, 2022 | Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SLC12A2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This missense change has been observed in individual(s) with clinical features of SLC12A2-related conditions (Invitae). This variant is present in population databases (no rsID available, gnomAD 0.01%). This sequence change replaces valine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 18 of the SLC12A2 protein (p.Val18Phe). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at